Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Not applicableStudy completedNCT02252666
What this trial is testing

Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of Wisconsin, Madison 6
Not applicableLooking for participantsNCT06201026
What this trial is testing

Effects of Individualized Training to Reduce Fatigue in Patients With Newly and Advanced Diagnosed Multiple Sclerosis

Who this might be right for
SclerosisFatigue
Centre Hospitalier Universitaire de Saint Etienne 96
Large-scale testing (Phase 3)Active Not RecruitingNCT04695080
What this trial is testing

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

Who this might be right for
Advanced Multiple SclerosisProgressive Multiple Sclerosis
Queen Mary University of London 204
Not applicableUnknownNCT06506929
What this trial is testing

Task Specific Training for Advanced Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hunter College of City University of New York 15
Not applicableStudy completedNCT03564496
What this trial is testing

Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRI

Who this might be right for
Multiple Sclerosis
NYU Langone Health 73
Early research (Phase 1)Looking for participantsNCT03816345
What this trial is testing

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Who this might be right for
Autoimmune DiseaseCrohn DiseaseDermatomyositis+11 more
National Cancer Institute (NCI) 300
Not applicableEnrolling By InvitationNCT06460077
What this trial is testing

Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging

Who this might be right for
Multiple Sclerosis
Turku University Hospital 15
Post-approval studies (Phase 4)Study completedNCT01395316
What this trial is testing

Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Chicago 8
Not applicableLooking for participantsNCT05177523
What this trial is testing

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)Relapsing-remitting Multiple Sclerosis (RRMS)Secondary-progressive Multiple Sclerosis (SPMS)+1 more
University Hospital, Basel, Switzerland 300